Dexisometheptene mucate (Tonix Pharmaceuticals)

N/A

Report date: 2022/07/19 20:00:45
NME

Base Information

Drug NameDexisometheptene mucate (Tonix Pharmaceuticals)
Drug Alias NameTNX-201(R)-isometheptene mucate
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNischarin agonists
TargetsNischarin
Therapy Area/IndicationsTension-Type Headache
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesTonix Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTonix Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsTension-Type Headache

Other Information

ATC CodeN/A
Related LinksN/A